Vitamin K as Additive Treatment in Osteoporosis

NCT01232647 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Post-menopausal Osteoporosis

Interventions

DRUG: Phylloquinone
DRUG: Menatetrenone (MK4)
DRUG: placebo

Sponsor

Guy's and St Thomas' NHS Foundation Trust